## Timeline of Antithyroid Drug Action **Key Point:** Antithyroid drugs (PTU and methimazole) do NOT achieve euthyroid state within 24–48 hours. They work by inhibiting new thyroid hormone synthesis, but the body's large preformed hormone pool must be depleted first. ### Pharmacodynamics of Antithyroid Agents | Drug | Mechanism | Onset of Action | Peak Effect | Special Features | |------|-----------|-----------------|-------------|------------------| | **Propylthiouracil (PTU)** | Blocks TPO (hormone synthesis) + inhibits peripheral T4→T3 conversion | 6–12 hours | 4–8 weeks | Preferred in pregnancy; rare agranulocytosis | | **Methimazole** | Blocks TPO (hormone synthesis only) | 6–12 hours | 4–8 weeks | Teratogenic (methimazole embryopathy); avoid 1st trimester | | **Propranolol** | β-blocker; blocks peripheral T4→T3 conversion (minor) | **1–2 hours** | Immediate | Used for symptom control while awaiting antithyroid effect | **High-Yield:** The lag between drug initiation and clinical euthyroidism is **4–8 weeks** because: 1. Antithyroid drugs only block NEW hormone synthesis 2. The thyroid gland stores 2–3 months of preformed T3 and T4 3. Circulating T4 has a half-life of ~7 days; T3 has a half-life of ~2 days 4. Peripheral conversion of T4 to T3 continues during this period ### Why Propranolol is Essential **Clinical Pearl:** Propranolol provides rapid symptom relief (palpitations, tremor, anxiety) within 1–2 hours while the antithyroid drug takes weeks to normalize thyroid hormone levels. This is why β-blockers are first-line for symptomatic control in acute hyperthyroidism. ### PTU vs. Methimazole in Pregnancy **Mnemonic — PTU in Pregnancy:** **PTU = Pregnancy Thyroid Utility** - **PTU:** Safe in 1st trimester (no embryopathy); inhibits peripheral T4→T3 conversion (additional benefit) - **Methimazole:** Associated with methimazole embryopathy (rare but includes esophageal atresia, choanal atresia); avoid 1st trimester; safe in 2nd/3rd trimester ### Radioactive Iodine & Thyroid Eye Disease **Warning:** Radioactive iodine can worsen or precipitate thyroid eye disease (Graves' ophthalmopathy) in 15–20% of patients, especially if TSH is not adequately suppressed post-treatment. Patients with active eye disease should receive: - Antithyroid drugs to achieve euthyroidism first, OR - Glucocorticoids (e.g., prednisolone) perioperatively to reduce ophthalmopathy risk - Thyroidectomy may be preferred if active eye disease is present
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.